147 related articles for article (PubMed ID: 32278809)
1. What can we learn about functional importance of human antimicrobial peptide LL-37 in the oral environment from severe congenital neutropenia (Kostmann disease)?
Nilsson BO
Peptides; 2020 Jun; 128():170311. PubMed ID: 32278809
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.
Pütsep K; Carlsson G; Boman HG; Andersson M
Lancet; 2002 Oct; 360(9340):1144-9. PubMed ID: 12387964
[TBL] [Abstract][Full Text] [Related]
3. Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia.
Carlsson G; Wahlin YB; Johansson A; Olsson A; Eriksson T; Claesson R; Hänström L; Henter JI
J Periodontol; 2006 Apr; 77(4):744-51. PubMed ID: 16584360
[TBL] [Abstract][Full Text] [Related]
4. Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis.
Gutner M; Chaushu S; Balter D; Bachrach G
Infect Immun; 2009 Dec; 77(12):5558-63. PubMed ID: 19805540
[TBL] [Abstract][Full Text] [Related]
5. Salivary LL-37 secretion in individuals with Down syndrome is normal.
Bachrach G; Chaushu G; Zigmond M; Yefenof E; Stabholz A; Shapira J; Merrick J; Chaushu S
J Dent Res; 2006 Oct; 85(10):933-6. PubMed ID: 16998135
[TBL] [Abstract][Full Text] [Related]
6. Oral microbial dysbiosis in patients with Kostmann syndrome.
Topcuoglu N; Erdem AP; Karacan I; Kulekci G
J Med Microbiol; 2019 Apr; 68(4):609-615. PubMed ID: 30875283
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa.
Cirioni O; Ghiselli R; Tomasinsig L; Orlando F; Silvestri C; Skerlavaj B; Riva A; Rocchi M; Saba V; Zanetti M; Scalise G; Giacometti A
Shock; 2008 Oct; 30(4):443-8. PubMed ID: 18391859
[TBL] [Abstract][Full Text] [Related]
8. The cysteine protease ApdS from
Xie F; Zan Y; Zhang Y; Zheng N; Yan Q; Zhang W; Zhang H; Jin M; Chen F; Zhang X; Liu S
J Biol Chem; 2019 Nov; 294(47):17962-17977. PubMed ID: 31619521
[No Abstract] [Full Text] [Related]
9. Exogenous LL-37 but not homogenates of desquamated oral epithelial cells shows activity against
Aidoukovitch A; Bankell E; Davies JR; Nilsson BO
Acta Odontol Scand; 2021 Aug; 79(6):466-472. PubMed ID: 33687301
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D3 induces pro-LL-37 expression in myeloid precursors from patients with severe congenital neutropenia.
Karlsson J; Carlsson G; Larne O; Andersson M; Pütsep K
J Leukoc Biol; 2008 Nov; 84(5):1279-86. PubMed ID: 18703682
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial peptide LL-37 and its pro-form, hCAP18, in desquamated epithelial cells of human whole saliva.
Aidoukovitch A; Dahl S; Fält F; Nebel D; Svensson D; Tufvesson E; Nilsson BO
Eur J Oral Sci; 2020 Feb; 128(1):1-6. PubMed ID: 31825534
[TBL] [Abstract][Full Text] [Related]
12. Dysbiosis of the Oral Ecosystem in Severe Congenital Neutropenia Patients.
Zaura E; Brandt BW; Buijs MJ; Emingil G; Ergüz M; Karapinar DY; Pekpinarli B; Bao K; Belibasakis GN; Bostanci N
Proteomics Clin Appl; 2020 May; 14(3):e1900058. PubMed ID: 32026584
[TBL] [Abstract][Full Text] [Related]
13. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
Tjabringa GS; Rabe KF; Hiemstra PS
Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
[TBL] [Abstract][Full Text] [Related]
14. Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia.
Karlsson J; Carlsson G; Ramme KG; Hägglund H; Fadeel B; Nordenskjöld M; Henter JI; Palmblad J; Pütsep K; Andersson M
Br J Haematol; 2007 Apr; 137(2):166-9. PubMed ID: 17391497
[TBL] [Abstract][Full Text] [Related]
15. Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cells.
Khandagale A; Holmlund T; Entesarian M; Nilsson D; Kalwak K; Klaudel-Dreszler M; Carlsson G; Henter JI; Nordenskjöld M; Fadeel B
Br J Haematol; 2021 Jan; 192(1):200-211. PubMed ID: 33206996
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37.
Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F
Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544
[TBL] [Abstract][Full Text] [Related]
17. The host defense peptide LL-37 is detected in human parotid and submandibular/sublingual saliva and expressed in glandular neutrophils.
Svensson D; Aidoukovitch A; Anders E; Agerberth B; Andersson F; Ekblad E; Ericson D; Nebel D; Voss U; Nilsson BO
Eur J Oral Sci; 2018 Apr; 126(2):93-100. PubMed ID: 29424090
[TBL] [Abstract][Full Text] [Related]
18. Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria.
Puklo M; Guentsch A; Hiemstra PS; Eick S; Potempa J
Oral Microbiol Immunol; 2008 Aug; 23(4):328-35. PubMed ID: 18582333
[TBL] [Abstract][Full Text] [Related]
19. Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13.
Bucki R; Namiot DB; Namiot Z; Savage PB; Janmey PA
J Antimicrob Chemother; 2008 Aug; 62(2):329-35. PubMed ID: 18456648
[TBL] [Abstract][Full Text] [Related]
20. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
Nagaoka I; Tamura H; Hirata M
J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
